Funded Startups in Mölndal
Among the 5 most recent Mölndal-funded entries, the largest disclosed round is Ribocure Pharmaceuticals at $33M (2025-07-02), which sits well above most ot…
Among the 5 most recent Mölndal-funded entries, the largest disclosed round is Ribocure Pharmaceuticals at $33M (2025-07-02), which sits well above most other disclosed amounts in the list: only Vicore Pharma’s $46M (2023-06-09) is higher, while two other rounds are clustered near the single-digit to low-teens range ($8M on 2025-06-20 for Cereno Scientific AB; $5M on 2024-06-13 for Integrum). The amounts show a clear outlier at the top end: Vicore Pharma’s $46M (2023-06-09) is substantially larger than the rest of the disclosed figures.
Date-wise, the most recent two rounds land within about two weeks in 2025 (Cereno Scientific AB on 2025-06-20 for $8M and Ribocure Pharmaceuticals on 2025-07-02 for $33M), while the oldest entry shown dates back to 2021-05-23 (OnDosis at $11M). Sector-wise, Biotechnology appears in 2 entries (Ribocure Pharmaceuticals, Vicore Pharma) and Health Care appears in 2 entries (Cereno Scientific AB, OnDosis), with Medical Device represented once (Integrum). All 5 rows list “Series Unknown.”
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Mölndal list, and how does it compare to the other disclosed amounts?
Vicore Pharma’s $46M on 2023-06-09 is the top disclosed figure and is substantially larger than the rest; the next-highest disclosed amount is Ribocure Pharmaceuticals’ $33M on 2025-07-02, with remaining disclosed rounds of $11M (OnDosis, 2021-05-23), $8M (Cereno Scientific AB, 2025-06-20), and $5M (Integrum, 2024-06-13).
Is there a concentration of funding activity in a narrow recent time window?
Yes. Two of the five rounds fall within roughly two weeks in 2025-06-20 (Cereno Scientific AB, $8M) and 2025-07-02 (Ribocure Pharmaceuticals, $33M), while the other entries are spaced across 2024-06-13 (Integrum, $5M), 2023-06-09 (Vicore Pharma, $46M), and 2021-05-23 (OnDosis, $11M).
Do any sectors appear to be over-represented among these Mölndal entries?
No single sector dominates: Health Care and Biotechnology each appear twice (Cereno Scientific AB and OnDosis; Ribocure Pharmaceuticals and Vicore Pharma), and Medical Device appears once (Integrum on 2024-06-13 for $5M).
What’s the stage mix here, and does it suggest a limitation in comparability?
All 5 rows are labeled “Series Unknown” (Ribocure Pharmaceuticals on 2025-07-02 through OnDosis on 2021-05-23), so stage-based comparisons aren’t possible from the provided classifications.
Are there outliers worth flagging for diligence beyond the largest round?
The largest round is also a key outlier (Vicore Pharma’s $46M on 2023-06-09). On the low end, Integrum’s $5M on 2024-06-13 is the smallest disclosed amount in the list, creating a wide spread between the lowest and highest disclosed rounds ($5M vs. $46M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.